Publication | Open Access
Opportunities and challenges following approval of resmetirom for MASH liver disease
52
Citations
6
References
2024
Year
GastroenterologyPathologyMash Liver DiseaseCirrhosisTranslational MedicineHepatic DisordersHepatotoxicityHepatology FibrosisMetabolic Associated SteatohepatitisLiver PhysiologyHepatology InflammationPharmacologyDrug-induced Liver InjuryHepatologyHepatitisLiver DiseaseLiver CancerLiverMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1